Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53

Hepatocellular carcinoma (HCC) is a prevalent problem worldwide. Chemotherapy, especially cisplatin (CDDP)-based systemic chemotherapy, is the best option for advanced liver cancer. However, CDDP resistance is becoming common and hindering the clinical application of CDDP. Meanwhile, no consensus ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Li, Zhanjun, Tu, Min, Han, Bei, Gu, Yuqing, Xue, Xiaofeng, Sun, Jie, Ge, Qianqian, Miao, Yi, Qian, Zhuyin, Gao, Wentao
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3942424/
https://ncbi.nlm.nih.gov/pubmed/24595063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0090358
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados